prof. dr. B. (Reinier) Sterenborg

prof. dr. B. (Reinier) Sterenborg

Associate Professor - medical
prof. dr. B. (Reinier) Sterenborg
  • Department of Hematology

Research Output (76)

Vaccine responses in adult hematopoietic stem cell transplant recipients:A comprehensive review

Janssen Michelle, Bruns Anke, Kuball Jürgen, Raijmakers Reinier, van Baarle Debbie 6 Dec 2021, In: Cancers. 13 , p. 1-18

αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies

De Witte Moniek A., Janssen Anke, Nijssen Klaartje, Karaiskaki Froso, Swanenberg Luuk, van Rhenen Anna, Admiraal Rick, van der Wagen Lotte, Minnema Monique C., Petersen Eefke, Raymakers Reinier A.P., Westinga Kasper, Straetemans Trudy, Halkes Constantijn J.M., Boelens Jaap Jan, Kuball Jurgen 12 Jan 2021, In: Blood Advances. 5 , p. 240-249 10 p.

CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis

Leguit Roos J., Raymakers Reinier A.P., Hebeda Konnie M., Goldschmeding Roel 2021, In: Journal of Cell Communication and Signaling. 15 , p. 25-56 32 p.

Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations:Count and Adjust

de Witte Moniek, Daenen Laura G M, van der Wagen Lotte, van Rhenen Anna, Raymakers Reiner, Westinga Kasper, Kuball Jürgen 2021, In: HemaSphere. 5 , p. 1-12 12 p.

Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients

Janssen Michelle J.M., Bruns Anke H.W., Verduyn Lunel Frans M., Raijmakers Reinier A.P., de Weijer Roel J., Nanlohy Nening M., Smits Gaby P., van Baarle Debbie, Kuball Jürgen 2021, In: Bone Marrow Transplantation. 56 , p. 2922-2928 7 p.

EBV-related lymphoma after long-term daratumumab treatment:a case report

Verpoorte-Botden Ilse P G, Minnema Monique C, Raymakers Reinier A P 1 Nov 2020, In: Blood cancer journal. 10

Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy:results from the HOVON 109 study

Saberi Hosnijeh Fatemeh, van der Straten Lina, Kater Arnon P., van Oers Marinus H.J., Posthuma Ward F.M., Chamuleau Martine E.D., Bellido Mar, Doorduijn Jeanette K., van Gelder Michel, Hoogendoorn Mels, de Boer Fransien, te Raa G. Doreen, Kerst J. Martijn, Marijt Erik W.A., Raymakers Reinier A.P., Koene Harry R., Schaafsma Martijn R., Dobber Johan A., Tonino Sanne H., Kersting Sabina S., Langerak Anton W., Levin Mark David Sep 2020, In: Experimental Hematology. 89 , p. 55-60.e6

Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis

Barraco Fiorenza, Greil Richard, Herbrecht Raoul, Schmidt Burkhard, Reiter Andreas, Willenbacher Wolfgang, Raymakers Reinier, Liersch Rüdiger, Wroclawska Monika, Pack Robert, Burock Karin, Karumanchi Divyadeep, Gisslinger Heinz 24 Jun 2020, In: British Journal of Haematology. 191 , p. 764-774 11 p.

Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome

Niessen F. A., Van Mourik M. S.M., Bruns A. H.W., Raijmakers R. A.P., De Groot M. C.H., Van Der Bruggen T. 27 May 2020, In: Antimicrobial Resistance and Infection Control. 9 10 p.

Dexamethasone synergizes with MCL-1 inhibition in multiple myeloma through suppression of S6 phosphorylation

Spaan Ingrid, Timmerman Laura, Kimman Thoman, Slomp Anne, Cuenca Marta, Minnema Monique, Raymakers Reinier, Peperzak Victor Oct 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19 , p. E110-E110

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not